fenoldopam has been researched along with Pulmonary Fibrosis in 1 studies
Fenoldopam: A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.
Pulmonary Fibrosis: A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.
Excerpt | Relevance | Reference |
---|---|---|
"Idiopathic pulmonary fibrosis (IPF) is the most common fatal interstitial lung disease, with limited therapeutic options." | 1.62 | Dopamine receptor agonists ameliorate bleomycin-induced pulmonary fibrosis by repressing fibroblast differentiation and proliferation. ( Liu, J; Miao, K; Mou, Y; Pan, T; Wang, Q; Xiong, W; Xu, Y; Yu, J, 2021) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Mou, Y | 1 |
Liu, J | 1 |
Pan, T | 1 |
Wang, Q | 1 |
Miao, K | 1 |
Xu, Y | 1 |
Xiong, W | 1 |
Yu, J | 1 |
1 other study available for fenoldopam and Pulmonary Fibrosis
Article | Year |
---|---|
Dopamine receptor agonists ameliorate bleomycin-induced pulmonary fibrosis by repressing fibroblast differentiation and proliferation.
Topics: Animals; Antibiotics, Antineoplastic; Benzimidazoles; Bleomycin; Cell Differentiation; Cell Prolifer | 2021 |